← Back to Search

Peer Support Program for Quitting Vaping (V2V Trial)

N/A

Waitlist Available

Led By Rajani Sadasivam, PhD

Research Sponsored by University of Massachusetts, Worcester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

V2V Trial Summary

This trial will develop tools to help adolescents quit e-cigarettes, which have a high amount of nicotine & put them at risk of becoming traditional smokers.

Who is the study for?

This trial is for high school students in grades 9-12 who currently use e-cigarettes and can communicate in English or Spanish. Participants must have used an e-cigarette at least once in the past week and own a smartphone. Those unable to give informed consent or assent are excluded.Check my eligibility

What is being tested?

The study tests Vaper-to-Vaper (V2V), a mobile tool suite that includes peer texting, coaching, gamification, and cessation materials designed to help adolescents quit vaping by managing cravings.See study design

What are the potential side effects?

Since this intervention involves behavioral support rather than medication, traditional side effects are not expected; however, participants may experience stress or frustration during the quitting process.

V2V Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Participant Recruitment and Retention

Secondary outcome measures

Abstinence from Vaping as measured by Saliva Samples [Cotinine-validated 7-day point prevalence]

Acceptability of and Satisfaction with the Intervention

Change in Self-Control Behavioral Capability

+10 more

V2V Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment3 Interventions

Students in school randomized to the intervention will receive: (1) peer messages, written by current and former adolescent e-cigarette users and tailored by age and readiness-to-quit; (2) peer coaching, facilitated by texting; and (3) gamification, designed to motivate participation.

Group II: ControlActive Control1 Intervention

Students in schools randomized to the control condition will be provided written e-cigarette cessation materials by the Research Coordinator at the time of study enrollment. The written materials will consist of two pamphlets from Journeyworks, selected based on: (1) their clear and attractive layout designed for a low-literacy audience, and (2) their providing both information re: e-cigarette use with a strong message about nicotine and nicotine addiction, E-Cigarettes: 8 Things Everyone Should Know, and support in quitting, How to Quit Vaping.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Gamification

2019

Completed Phase 3

~2230

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH

2,470 Previous Clinical Trials

2,619,651 Total Patients Enrolled

University of Massachusetts, WorcesterLead Sponsor

343 Previous Clinical Trials

986,530 Total Patients Enrolled

Rajani Sadasivam, PhDPrincipal InvestigatorUniversity of Massachusetts Chan Medical School

3 Previous Clinical Trials

3,037 Total Patients Enrolled

Media Library

Peer Coaching via Text Clinical Trial Eligibility Overview. Trial Name: NCT05140915 — N/A

E-Cigarette Use Research Study Groups: Control, Intervention

E-Cigarette Use Clinical Trial 2023: Peer Coaching via Text Highlights & Side Effects. Trial Name: NCT05140915 — N/A

Peer Coaching via Text 2023 Treatment Timeline for Medical Study. Trial Name: NCT05140915 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the criteria for eligibility in this experiment?

"To participate in this trial, adolescents aged between 13 and 19 who vape need to apply. This clinical investigation will enlist a total of 80 individuals."

Answered by AI

Does this study accept individuals who are of legal age?

"The parameters of this trial dictate that participants must be between 13 and 19 years old. There are nine trials for individuals under 18 and four more specifically targeting those over 65."

Answered by AI

Are there still opportunities for participation in this medical trial?

"As found on clinicaltrials.gov, this medical study is not currently recruiting any participants. It was initially posted on December 19th 2022 and last edited March 14th 2023. In contrast to the current status of this trial, 18 other studies are actively accepting patients as we speak."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Vaper to Vaper: A Multimodal Mobile Peer Driven Intervention to Support Adolescents in Quitting Vaping

Rajani Sadasivam 2022. "Vaper to Vaper: A Multimodal Mobile Peer Driven Intervention to Support Adolescents in Quitting Vaping". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05140915.